EyeCool Therapeutics Announces Encouraging Interim Clinical Results for ETX-4143 in Chronic Ocular…

BOSTON, MA — January 8, 2026 — EyeCool Therapeutics, a clinical-stage ophthalmic medical device company, today announced encouraging…